{
  "DOI": "10.1007/s12687-016-0266-4",
  "ISSN": [
    "1868-310X",
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-016-0266-4",
  "alternative-id": [
    "266"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Slade",
      "given": "Ingrid",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "name": "for the MCG programme",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Hanson",
      "given": "Helen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "George",
      "given": "Angela",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kohut",
      "given": "Kelly",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Strydom",
      "given": "Ann",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wordsworth",
      "given": "Sarah",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rahman",
      "given": "Nazneen",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2016,
        2,
        27
      ]
    ],
    "date-time": "2016-02-27T01:46:26Z",
    "timestamp": 1456537586000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        3,
        26
      ]
    ],
    "date-time": "2019-03-26T15:14:53Z",
    "timestamp": 1553613293000
  },
  "funder": [
    {
      "DOI": "10.13039/100004440",
      "award": [
        "098518/Z/12/Z"
      ],
      "doi-asserted-by": "publisher",
      "name": "Wellcome Trust (GB)"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        1
      ]
    ],
    "date-time": "2024-03-01T17:10:48Z",
    "timestamp": 1709313048297
  },
  "is-referenced-by-count": 25,
  "issn-type": [
    {
      "type": "print",
      "value": "1868-310X"
    },
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2016,
        2,
        27
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2016,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0",
      "content-version": "unspecified",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2016,
            2,
            27
          ]
        ],
        "date-time": "2016-02-27T00:00:00Z",
        "timestamp": 1456531200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-016-0266-4.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s12687-016-0266-4/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s12687-016-0266-4",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "185-194",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2016,
        2,
        27
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2016,
        2,
        27
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2016,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "key": "266_CR1",
      "unstructured": "(2003) “Our Inheritance, Our Future. Realising the potential of genetics in the NHS.” London: Department of Health, Scientific Development and Bioethics Division"
    },
    {
      "key": "266_CR2",
      "unstructured": "(2009) “Genomic Medicine”. London: House of Lords, Science and Technology Committee"
    },
    {
      "key": "266_CR3",
      "unstructured": "(2013) “Realising the potential of stratified medicine.” London: The Academy of Medical Sciences"
    },
    {
      "key": "266_CR4",
      "unstructured": "(2012) “NHS reference costs”. NHS reference costs: financial year 2012 to 2013. London: Department of Health"
    },
    {
      "key": "266_CR5",
      "unstructured": "(2012) “Unit costs of health and social care 2012.” Edited by Lesley Curtis. Canterbury, Kent: University of Kent, Personal Social Services Research Unit"
    },
    {
      "DOI": "10.1200/JCO.2011.39.8545",
      "author": "K Alsop",
      "doi-asserted-by": "crossref",
      "first-page": "2664",
      "journal-title": "J Clin Oncol",
      "key": "266_CR6",
      "unstructured": "Alsop K, Fereday S, Meldrum C, deFazio A, Emmanuel C, George J, Dobrovic A, Birrer MJ, Webb PM, Stewart C, Friedlander M, Fox S, Bowtell D, Mitchell G (2012) BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol 30:2664–2663",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "journal-title": "Am J Hum Genet",
      "key": "266_CR7",
      "unstructured": "Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "author": "A Brand",
      "first-page": "177",
      "journal-title": "Drug Metabol Drug Interact",
      "key": "266_CR8",
      "unstructured": "Brand A, Lal JA (2012) European best practice guidelines for quality assurance, provision and use of genome-based information and technologies: the 2012 declaration of Rome. Drug Metabol Drug Interact 27:177–182",
      "volume": "27",
      "year": "2012"
    },
    {
      "DOI": "10.2217/pgs.13.183",
      "author": "J Buchanan",
      "doi-asserted-by": "crossref",
      "first-page": "1833",
      "journal-title": "Pharmacogenomics",
      "key": "266_CR9",
      "unstructured": "Buchanan J, Wordsworth S, Schuh A (2013) Issues surrounding the health economic evaluation of genomic technologies. Pharmacogenomics 14:1833–1847",
      "volume": "14",
      "year": "2013"
    },
    {
      "author": "H Burton",
      "key": "266_CR10",
      "unstructured": "Burton H (2011) Genetics and mainstream medicine. Service development and integration. Public Health Genomics Foundation, Cambridge",
      "volume-title": "Genetics and mainstream medicine. Service development and integration",
      "year": "2011"
    },
    {
      "DOI": "10.1159/000279625",
      "author": "H Burton",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "journal-title": "Public Health Genomics",
      "key": "266_CR11",
      "unstructured": "Burton H, Alberg C, Stewart A (2010) Mainstreaming genetics: a comparative review of clinical services for inherited cardiovascular conditions in the UK. Public Health Genomics 13:235–245",
      "volume": "13",
      "year": "2010"
    },
    {
      "DOI": "10.1186/bcr3231",
      "author": "T Byrski",
      "doi-asserted-by": "crossref",
      "first-page": "R110",
      "journal-title": "Breast Cancer Res : BCR",
      "key": "266_CR12",
      "unstructured": "Byrski T, Dent R, Blecharz P, Foszczynska-Kloda M, Gronwald J, Huzarski T, Cybulski C, Marczyk E, Chrzan R, Eisen A, Lubinski J, Narod SA (2012) Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer. Breast Cancer Res : BCR 14:R110",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-09-0171",
      "author": "DG Evans",
      "doi-asserted-by": "crossref",
      "first-page": "2318",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "266_CR13",
      "unstructured": "Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, Brain A, Hopwood P, Howell A (2009) Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomarkers Prev 18:2318–2324",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMoa0900212",
      "author": "PC Fong",
      "doi-asserted-by": "crossref",
      "first-page": "123",
      "journal-title": "N Engl J Med",
      "key": "266_CR14",
      "unstructured": "Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O’Connor MJ, Ashworth A, Carmichael J, Kaye SB, Schellens JH, de Bono JS (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361:123–134",
      "volume": "361",
      "year": "2009"
    },
    {
      "author": "A Gray",
      "key": "266_CR15",
      "unstructured": "Gray A, Clarke P, Wolstenholme J, Wordsworth S (2011) Applied methods of cost-effectiveness analysis in health care. Oxford University Press, Oxford",
      "volume-title": "Applied methods of cost-effectiveness analysis in health care",
      "year": "2011"
    },
    {
      "DOI": "10.1038/sj.bjc.6603356",
      "author": "I Griebsch",
      "doi-asserted-by": "crossref",
      "first-page": "801",
      "journal-title": "Br J Cancer",
      "key": "266_CR16",
      "unstructured": "Griebsch I, Brown J, Boggis C, Dixon A, Dixon M, Easton D, Eeles R, Evans DG, Gilbert FJ, Hawnaur J, Kessar P, Lakhani SR, Moss SM, Nerurkar A, Padhani AR, Pointon LJ, Potterton J, Thompson D, Turnbull LW, Walker LG, Warren R, Leach MO (2006) Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer 95:801–810",
      "volume": "95",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1524-4733.2008.00418.x",
      "author": "ML Holland",
      "doi-asserted-by": "crossref",
      "first-page": "207",
      "journal-title": "Value Health",
      "key": "266_CR17",
      "unstructured": "Holland ML, Huston A, Noyes K (2009) Cost-effectiveness of testing for breast cancer susceptibility genes. Value Health 12:207–216",
      "volume": "12",
      "year": "2009"
    },
    {
      "DOI": "10.1200/JCO.2008.21.4684",
      "author": "JS Kwon",
      "doi-asserted-by": "crossref",
      "first-page": "675",
      "journal-title": "J Clin Oncol",
      "key": "266_CR18",
      "unstructured": "Kwon JS, Daniels MS, Sun CC, Lu KH (2010) Preventing future cancers by testing women with ovarian cancer for BRCA mutations. J Clin Oncol 28:675–682",
      "volume": "28",
      "year": "2010"
    },
    {
      "DOI": "10.1200/JCO.2003.09.052",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "crossref",
      "first-page": "1675",
      "journal-title": "J Clin Oncol",
      "key": "266_CR19",
      "unstructured": "Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG (2003) Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. J Clin Oncol 21:1675–1681",
      "volume": "21",
      "year": "2003"
    },
    {
      "DOI": "10.1002/ijc.23340",
      "author": "KA Metcalfe",
      "doi-asserted-by": "crossref",
      "first-page": "2017",
      "journal-title": "Int J Cancer",
      "key": "266_CR20",
      "unstructured": "Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122:2017–2022",
      "volume": "122",
      "year": "2008"
    },
    {
      "key": "266_CR21",
      "unstructured": "NICE (2013) “Familial Breast Cancer. Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. Clinical guideline 164. https://www.nice.org.uk/guidance/cg164 .” Manchester: National Institute for Health and Care Excellence"
    },
    {
      "DOI": "10.1038/nature12981",
      "author": "N Rahman",
      "doi-asserted-by": "crossref",
      "first-page": "302",
      "journal-title": "Nature",
      "key": "266_CR22",
      "unstructured": "Rahman N (2014) Realizing the promise of cancer predisposition genes. Nature 505:302–308",
      "volume": "505",
      "year": "2014"
    },
    {
      "DOI": "10.1038/nrg1325",
      "author": "J Shendure",
      "doi-asserted-by": "crossref",
      "first-page": "335",
      "journal-title": "Nat Rev Genet",
      "key": "266_CR23",
      "unstructured": "Shendure J, Mitra RD, Varma C, Church GM (2004) Advanced sequencing technologies: methods and goals. Nat Rev Genet 5:335–344",
      "volume": "5",
      "year": "2004"
    },
    {
      "DOI": "10.1089/gtmb.2011.0236",
      "author": "W Sullivan",
      "doi-asserted-by": "crossref",
      "first-page": "580",
      "journal-title": "Genet Test Mol Biomarkers",
      "key": "266_CR24",
      "unstructured": "Sullivan W, Evans DG, Newman WG, Ramsden SC, Scheffer H, Payne K (2012) Developing national guidance on genetic testing for breast cancer predisposition: the role of economic evidence? Genet Test Mol Biomarkers 16:580–591",
      "volume": "16",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.ejrad.2010.10.025",
      "author": "S Taylor-Phillips",
      "doi-asserted-by": "crossref",
      "first-page": "60",
      "journal-title": "Eur J Radiol",
      "key": "266_CR25",
      "unstructured": "Taylor-Phillips S, Wallis MG, Duncan A, Gale AG (2012) Use of prior mammograms in the transition to digital mammography: a performance and cost analysis. Eur J Radiol 81:60–65",
      "volume": "81",
      "year": "2012"
    },
    {
      "DOI": "10.1038/sj.bjc.6603248",
      "author": "N Torrance",
      "doi-asserted-by": "crossref",
      "first-page": "435",
      "journal-title": "Br J Cancer",
      "key": "266_CR26",
      "unstructured": "Torrance N, Mollison J, Wordsworth S, Gray J, Miedzybrodzka Z, Haites N, Grant A, Campbell M, Watson MS, Clarke A, Wilson B (2006) Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials. Br J Cancer 95:435–444",
      "volume": "95",
      "year": "2006"
    },
    {
      "DOI": "10.1186/bcr3332",
      "author": "NC Turner",
      "doi-asserted-by": "crossref",
      "first-page": "115",
      "journal-title": "Breast Cancer Res : BCR",
      "key": "266_CR27",
      "unstructured": "Turner NC, Tutt AN (2012) Platinum chemotherapy for BRCA1-related breast cancer: do we need more evidence? Breast Cancer Res : BCR 14:115",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1093/annonc/mdt068",
      "author": "PM Vencken",
      "doi-asserted-by": "crossref",
      "first-page": "2036",
      "journal-title": "Ann Oncol",
      "key": "266_CR28",
      "unstructured": "Vencken PM, Reitsma W, Kriege M, Mourits MJ, de Bock GH, de Hullu JA, van Altena AM, Gaarenstroom KN, Vasen HF, Adank MA, Schmidt MK, van Beurden M, Zweemer RP, Rijcken F, Slangen BF, Burger CW, Seynaeve C (2013) Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands. Ann Oncol 24:2036–2042",
      "volume": "24",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.ygyno.2011.01.020",
      "author": "S Zhang",
      "doi-asserted-by": "crossref",
      "first-page": "353",
      "journal-title": "Gynecol Oncol",
      "key": "266_CR29",
      "unstructured": "Zhang S, Royer R, Li S, McLaughlin JR, Rosen B, Risch HA, Fan I, Bradley L, Shaw PA, Narod SA (2011) Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer. Gynecol Oncol 121:353–357",
      "volume": "121",
      "year": "2011"
    }
  ],
  "reference-count": 29,
  "references-count": 29,
  "relation": {
    "has-preprint": [
      {
        "asserted-by": "object",
        "id": "10.1101/027185",
        "id-type": "doi"
      }
    ]
  },
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s12687-016-0266-4"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "A cost analysis of a cancer genetic service model in the UK"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "7"
}